HeartSciences Inc. (HSCS)
Official siteHEALTHCARE • MEDICAL DEVICES • NASDAQ
Market Cap: $10.56M
Last updated: Nov 17, 2026 at 11:01 AM ET
HeartSciences Inc. (HSCS) Stock Forecast
Analysts expect HeartSciences (HSCS) to earn -$2.46 per share in the fiscal year ending Apr 30, 2027, on revenue of $17100. Over the last 30 days, 1 estimate for the fiscal year ending Apr 30, 2027 was revised up and 0 down. For the fiscal year ending Apr 30, 2028, the EPS consensus is -$1.75.
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus shows a smaller loss and revenue estimates rise 18321.1%.
- Fiscal year ending Apr 30, 2027
- -$2.46
- EPS consensus, revenue $17100
- Fiscal year ending Apr 30, 2028
- -$1.75
- EPS consensus, revenue $3.15M
- Next report
- Dec 21, 2026
- Estimated
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Apr 30, 2027 | -$2.46 | -$2.46 to -$2.46 | 1 | $17100 | $17100 to $17100 | 1 |
| Apr 30, 2028 | -$1.75 | -$1.75 to -$1.75 | 1 | $3.15M | $3.15M to $3.15M | 1 |
Quarterly Estimates
The EPS consensus falls from -$0.61 for the quarter ending Jan 31, 2027 to -$0.65 for the quarter ending Apr 30, 2027.
Revenue range
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Jan 31, 2027 | -$0.61 | -$0.61 to -$0.61 | 1 | $5000 | $5000 to $5000 | 1 |
| Apr 30, 2027 | -$0.65 | N/A | 3 | $10200 | $9800 to $10500 | 3 |
Estimate Revisions
Across the 3 periods below, the last 30 days brought 3 upward and 0 downward EPS revisions. Raises outnumber cuts in every period.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Apr 30, 2027 | 1 | 0 |
| Fiscal year ending Apr 30, 2028 | 1 | 0 |
| Quarter ending Jan 31, 2027 | 1 | 0 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Apr 30, 2027 has improved from -$2.83.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Apr 30, 2027 | -$2.46 | -$2.46 | -$2.62 | -$2.62 | -$2.83 | N/A |
| Fiscal year ending Apr 30, 2028 | -$1.75 | -$1.86 | -$1.86 | -$1.93 | -$1.93 | N/A |
| Quarter ending Jan 31, 2027 | -$0.61 | -$0.61 | -$0.66 | -$0.66 | -$0.72 | N/A |
Frequently Asked Questions About HSCS
What is the HSCS stock forecast?
Consensus analyst estimates put HeartSciences's EPS at -$2.46 for the fiscal year ending Apr 30, 2027, on revenue of $17100.
What EPS do analysts expect from HSCS next year?
For the fiscal year ending Apr 30, 2027, the consensus EPS estimate is -$2.46, with estimates from -$2.46 to -$2.46 from 1 analyst. For the fiscal year ending Apr 30, 2028, the consensus EPS estimate is -$1.75, with estimates from -$1.75 to -$1.75 from 1 analyst.
What revenue do analysts expect from HeartSciences next year?
For the fiscal year ending Apr 30, 2027, the consensus revenue estimate is $17100, with estimates from $17100 to $17100. For the fiscal year ending Apr 30, 2028, the consensus revenue estimate is $3.15M, with estimates from $3.15M to $3.15M.
How many analysts cover HSCS?
1 analyst estimates EPS for HeartSciences for the fiscal year ending Apr 30, 2027.
HSCS pages: Overview, Earnings, Forecast, Financials, Competitors